# The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf

Canonical: https://abierto.us/opportunities/75n98026q01067

- Solicitation number: 75N98026Q01067
- Notice type: Special notice
- Status: Closed. Deadline was September 4, 2026 at 10:00 AM EDT
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: National Institutes of Health Nhlbi (75N920)
- NAICS: 621511 Medical Laboratories
- Product or service code: Q301 Reference Laboratory Testing
- First posted: August 28, 2026
- Last posted: August 28, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/13906e25b8a34a8ca5744c528fbc690c/view

## Description

The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension

## Publications

- August 28, 2026: Special notice, due September 4, 2026 at 10:00 AM EDT. Notice 13906e25b8a34a8ca5744c528fbc690c. https://sam.gov/workspace/contract/opp/13906e25b8a34a8ca5744c528fbc690c/view

## Points of contact

- BRUNING, NATALIE E, natalie.bruning@nih.gov, +1 000 000 0000

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75n98026q01067.